Literature DB >> 4434341

The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children.

R M Heyn, R Holland, W A Newton, M Tefft, N Breslow, J R Hartmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4434341     DOI： 10.1002/1097-0142(197412)34:6<2128::aid-cncr2820340638>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  18 in total

1.  [The rhabdomyosarcoma with regard to age, sex, localization, pathological anatomy, and prognosis (author's transl)].

Authors:  H Sulser
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-08-04

Review 2.  Current impact of adjuvant chemotherapy in resectable cancer.

Authors:  A Rossi; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Surgical lessons from the Intergroup Rhabdomyosarcoma Study (IRS) pertaining to extremity tumors.

Authors:  W Lawrence; D M Hays; R Heyn; M Beltangady; H M Maurer
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

4.  Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Authors:  Abha A Gupta; James R Anderson; Alberto S Pappo; Sheri L Spunt; Roshni Dasgupta; Daniel J Indelicato; Douglas S Hawkins
Journal:  Cancer       Date:  2011-07-14       Impact factor: 6.860

5.  The management of rhabdomyosarcoma in children and young adults.

Authors:  D M Hays
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

Review 6.  Non-uterine gynecological sarcomas.

Authors:  G Leppien
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

7.  18-Year-Old Woman with an Embryonal Rhabdomyosarcoma of the Uterus in Statu Nascendi.

Authors:  O Strahl; A Hartmann; F C Thiel; M W Beckmann; M P Lux
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-12       Impact factor: 2.915

8.  In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide-treated rats.

Authors:  M Dohadwala; P K Ray
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

9.  Chemotherapy of advanced neuroblastoma: does adriamycin contribute?

Authors:  J Ninane; J Pritchard; J S Malpas
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

10.  L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.

Authors:  J C Roberts; D J Francetic; R T Zera
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.